A detailed history of Groupama Asset Managment transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Groupama Asset Managment holds 34,058 shares of EW stock, worth $2.43 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
34,058
Previous 18,739 81.75%
Holding current value
$2.43 Million
Previous $1.73 Billion 4.24%
% of portfolio
0.05%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$59.7 - $93.78 $914,544 - $1.44 Million
15,319 Added 81.75%
34,058 $1.8 Billion
Q2 2024

Aug 14, 2024

SELL
$84.3 - $94.31 $51,591 - $57,717
-612 Reduced 3.16%
18,739 $1.73 Billion
Q1 2024

May 14, 2024

SELL
$72.54 - $95.56 $735,918 - $969,456
-10,145 Reduced 34.39%
19,351 $2.64 Billion
Q4 2023

Feb 14, 2024

BUY
$61.71 - $77.76 $1.82 Million - $2.29 Million
29,496 New
29,496 $2.25 Billion

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $44.1B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Groupama Asset Managment Portfolio

Follow Groupama Asset Managment and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Groupama Asset Managment, based on Form 13F filings with the SEC.

News

Stay updated on Groupama Asset Managment with notifications on news.